Summary & Overview
HCPCS G2161: Prior Adverse Reaction to Zoster Vaccine
HCPCS Level II code G2161 documents that a patient experienced a prior adverse reaction to the zoster vaccine or one of its components at any time during or before the measurement period. Nationally, clear documentation of vaccine-related adverse events supports patient safety, clinical decision-making, and alignment with immunization quality measures. The code is used in ambulatory and immunization settings where vaccination history influences future vaccine administration and monitoring.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of what the code represents, typical service settings, and why the code matters for clinical documentation and safety tracking. The publication outlines how the code is used for vaccine adverse event documentation, implications for care workflows, and how payers incorporate such codes into quality measurement and reporting workflows. Where available, benchmarking information, policy context, and coding considerations are summarized. Data not available in the input will be flagged as such.
Billing Code Overview
HCPCS Level II code G2161 indicates that a patient had a prior adverse reaction caused by zoster vaccine or its components at any time during or before the measurement period. This code documents a historical vaccine-related adverse event relevant to clinical decision-making and quality measurement.
-
Service type: Vaccine safety documentation and adverse reaction reporting
-
Typical site of service: Outpatient clinics, primary care offices, immunization clinics, and other ambulatory settings where vaccination history and safety are assessed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient presents to primary care or a vaccine clinic with a documented history of an adverse reaction to the zoster vaccine (live or recombinant) or to a vaccine component at any time before or during the measurement period. Typical workflow: review immunization history and allergy/adverse reaction documentation in the electronic health record; verify nature, timing, and severity of the prior reaction (local injection site reaction, systemic hypersensitivity, anaphylaxis, neurologic reaction, or other adverse event); determine vaccine contraindication or precaution status; document the presence of the prior adverse reaction in the medical record; bill the encounter or measure/report the exclusion using billing code G2161 to indicate the patient had a prior adverse reaction to zoster vaccine or its components. Typical site of service: outpatient clinic, primary care office, community immunization clinic, or specialty clinic (e.g., allergy/immunology). Typical patient scenario: an adult aged 50 years or older with an electronic record entry showing a prior immediate hypersensitivity reaction (urticaria and throat tightness) after receipt of a zoster vaccine five years earlier; patient is seen for immunization assessment and the reaction is documented as a contraindication to revaccination and reported using G2161. Common documentation elements: date and description of prior reaction, vaccine or component identified, treating clinician assessment that reaction constitutes a contraindication or exclusion, and counseling notes. Payors commonly involved in authorization, coverage, or quality reporting include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|